LPL Financial
GNOM icon

LPL Financial’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

LPL Financial’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19M Sell
27,166
-2,705
-9% -$125K ﹤0.01% 4030
2025
Q4 		$1.36M Sell
29,871
-2,821
-9% -$125K ﹤0.01% 3761
2025
Q3 		$1.27M Sell
32,692
-4,643
-12% -$168K ﹤0.01% 3769
2025
Q2 		$1.26M Buy
37,335
+12,892
+53% +$408K ﹤0.01% 3537
2025
Q1 		$777K Buy
24,443
+6,963
+40% +$264K ﹤0.01% 3766
2024
Q4 		$679K Buy
17,480
+225
+1% +$9.45K ﹤0.01% 3823
2024
Q3 		$776K Buy
17,255
+4,399
+34% +$197K ﹤0.01% 3625
2024
Q2 		$537K Buy
12,856
+680
+6% +$28.4K ﹤0.01% 3816
2024
Q1 		$554K Buy
12,176
+662
+6% +$30.2K ﹤0.01% 3688
2023
Q4 		$532K Buy
11,514
+683
+6% +$27.8K ﹤0.01% 3613
2023
Q3 		$441K Sell
10,831
-88
-0.8% -$4.01K ﹤0.01% 3591
2023
Q2 		$529K Sell
10,919
-2,801
-20% -$140K ﹤0.01% 3397
2023
Q1 		$676K Sell
13,720
-1,707
-11% -$87.8K ﹤0.01% 3092
2022
Q4 		$781K Sell
15,427
-90
-0.6% -$4.64K ﹤0.01% 2845
2022
Q3 		$779K Buy
15,517
+2,987
+24% +$169K ﹤0.01% 2731
2022
Q2 		$612K Sell
12,530
-5,189
-29% -$263K ﹤0.01% 3030
2022
Q1 		$1.06M Sell
17,719
-5,729
-24% -$361K ﹤0.01% 2566
2021
Q4 		$1.86M Sell
23,448
-3
-0% -$252 ﹤0.01% 2142
2021
Q3 		$2.08M Buy
23,451
+15,017
+178% +$1.41M ﹤0.01% 2012
2021
Q2 		$840K Buy
8,434
+608
+8% +$53.9K ﹤0.01% 2718
2021
Q1 		$704K Buy
7,826
+3,437
+78% +$339K ﹤0.01% 2724
2020
Q4 		$415K Buy
+4,389
New +$367K ﹤0.01% 2919

Other funds holding GNOM

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $236M AUM 12.89% 1-Year Est. Return

LPL Financial's GNOM Position: Q1 2026 in Review

LPL Financial reduced its Global X Genomics & Biotechnology ETF (GNOM) stake by 9.1% in Q1 2026, selling an estimated $125K and leaving 27,166 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #4030.

LPL Financial first reported a position in GNOM in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.08M in Q3 2021. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

  • LPL Financial held 27,166 shares of Global X Genomics & Biotechnology ETF worth $1.19M as of Q1 2026.
  • LPL Financial sold 2,705 Global X Genomics & Biotechnology ETF shares in Q1 2026, an estimated $125K.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #4030 holding.
  • LPL Financial first reported a position in Global X Genomics & Biotechnology ETF in Q4 2020 and has held it in 22 quarters since.
  • LPL Financial's Global X Genomics & Biotechnology ETF position peaked at $2.08M in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.